Process View
The chemical reactions and pathways involving mineralocorticoids, hormonal C21 corticosteroids synthesized from cholesterol. Mineralocorticoids act primarily on water and electrolyte balance.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "mineralocorticoid metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.990 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.912 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.730 | ||
| FSTL1 | follistatin-like 1 | 0.595 | ||
| NOG | noggin | 0.397 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.254 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.249 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.179 | ||
| MYO6 | myosin VI | 0.159 | ||
| FGF18 | fibroblast growth factor 18 | 0.150 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.089 | ||
| BMP4 | bone morphogenetic protein 4 | 0.085 | Human | |
| MAPK15 | mitogen-activated protein kinase 15 | 0.068 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.053 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.040 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.040 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.040 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.040 | ||
| FGF4 | fibroblast growth factor 4 | 0.037 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.031 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.031 | Human | |
| ACAN | aggrecan | 0.028 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.023 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.022 | ||
| WIF1 | WNT inhibitory factor 1 | 0.022 | ||
| BMP8A | bone morphogenetic protein 8a | 0.022 | Human | |
| SOX21 | SRY (sex determining region Y)-box 21 | 0.022 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.022 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.020 | Human | |
| WNT4 | wingless-type MMTV integration site family, member 4 | 0.020 | ||
| PAX2 | paired box 2 | 0.018 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.017 | Human | |
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.017 | ||
| CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 0.017 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.016 | ||
| KCNQ2 | potassium voltage-gated channel, KQT-like subfamily, member 2 | 0.015 | ||
| WNT3 | wingless-type MMTV integration site family, member 3 | 0.015 | Human | |
| FOXF2 | forkhead box F2 | 0.015 | ||
| FN1 | fibronectin 1 | 0.015 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.014 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.014 | ||
| P2RX2 | purinergic receptor P2X, ligand-gated ion channel, 2 | 0.014 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.014 | ||
| SMAD2 | SMAD family member 2 | 0.014 | ||
| IHH | Indian hedgehog | 0.013 | ||
| SMAD3 | SMAD family member 3 | 0.013 | ||
| EFNB3 | ephrin-B3 | 0.013 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.012 | ||
| WNT6 | wingless-type MMTV integration site family, member 6 | 0.012 | Human | |
| ALB | albumin | 0.012 | ||
| TBXA2R | thromboxane A2 receptor | 0.011 | ||
| POU3F1 | POU class 3 homeobox 1 | 0.011 | ||
| FGF3 | fibroblast growth factor 3 | 0.011 | ||
| HRH3 | histamine receptor H3 | 0.011 | ||
| HS3ST6 | heparan sulfate (glucosamine) 3-O-sulfotransferase 6 | 0.011 | ||
| CDX1 | caudal type homeobox 1 | 0.010 | ||
| AQP5 | aquaporin 5 | 0.010 | ||
| DLX4 | distal-less homeobox 4 | 0.010 | ||
| TG | thyroglobulin | 0.010 |